Director’s Voice Blog
The Future of Work: Evidence-based considerations for hybrid and remote work. For NIH and many other organizations within the research community, flexible workplaces continue to be the new normal as we head into 2023. According to a 2022 survey conducted by Pew Research Center, 59% of workers who responded that their jobs could primarily be done from home were in fact working from home all or most of the time, while 61% of workers who had an established workplace outside of their home chose not to go to their workplace. OBSSR prepared a summary of some of the current behavioral and social science evidence about two types of workplace flexibilities: hybrid (a mix of employees working in the office and from other locations) and remote (all employees working from other locations) work.
Read Full Blog
Behavioral and Social Sciences Research Spotlights
Medical jargon used in medical settings are poorly understood by patients and contribute to barriers in proper health care communication
The use of medical jargon by health care professionals has previously been identified as a barrier to patients’ proper understanding of their own health care status and outcomes. Despite the known consequences of using medical jargon in conveying health information, its use by health care professionals continues to be common. Past work has examined the use of jargon such as technical terminology, abbreviations, and acronyms, but few studies have explored understanding of “common medical jargon”—terms and phrases that may be commonly used in everyday language but have a different meaning in medicine. Recently published work supported by NCATS and others examined the understanding of medical jargon, specifically focusing on words and phrases with common meanings in regular English usage.
Some young adult males living in certain major U.S. cities face a higher risk of firearm death than military deployed in Iraq and Afghanistan
There has been an increase in violent crimes in the U.S., with 2020 data indicating a 30% increase in homicides with firearms, implying that firearm violence is becoming a leading cause of death for children, adolescents, and young adults. Recently published research funded by NIDA and NIGMS aimed to contextualize this public health crisis by comparing the risk of firearm-related death for young men living in the top 10% of the most violent zip codes areas in four major U.S. cities, with the risk of combat death and injury faced by U.S. military personnel who served during periods of war in Afghanistan and Iraq. Read More
Community mobilization efforts effective in preventing mpox transmission in the U.S.
According to an HHS press release dated Dec 2, 2022, it is not expected that the current mpox emergency declaration will be renewed when it ends on January 31, 2023, although case trends will continue to be monitored and vaccine distribution upheld in communities across the U.S. According to a recently published CDC morbidity and Mortality Weekly (MMWR) Report study, the U.S. mpox outbreak appears to have been thwarted due to the moderating effect of community mobilization and transmission prevention through outreach and vaccine distribution. This study was supported by NIMH, NINR, and others. Go There Now
News and Events
[Technical Assistance Webinar] PAR-23-066: Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention
Webinar date and time:
Thursday, January 26, 2023
1:00 p.m. ET
OBSSR is holding a technical assistance webinar related to the recently released funding opportunity announcement (FOA) PAR-23-066: Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Required).
FOA PAR-23-066 is a reissue of PAR-22-115 and solicits bi-phasic research projects proposed in UG3/UH3 Phased Innovation Awards Cooperative Agreement applications. Funding for the UG3 phase (phase I) will be used to demonstrate sufficient preparation, feasibility, and capacity to meet foundational milestone targets specific to the work proposed. A UG3 project that meets its milestones will be administratively considered by NIH and prioritized for transition to the UH3 award (phase II). Applicants responding to this FOA must address specific aims and milestones for both the UG3 and UH3 phases.
The webinar will provide an overview of PAR-23-066 and provide an opportunity to address participant questions. NIH staff will discuss the purpose and scope of these funding opportunities, go over the scientific review process, and review criteria and other logistical information. This webinar will include live captioning and will also be recorded and posted with captions on the OBSSR website until the March 18, 2023, FOA expiration date.
Individuals who need reasonable accommodation to participate in this event should contact Erica Moore at email@example.com or 301-594-4392.
OBSSR Director’s Webinar:
Michigan Integrative Well-Being and Inequality (MIWI) Training Program
The MIWI Training Program is a interdisciplinary methods training program that prepares participating scholars to investigate the intersection of mental and physical health, with an emphasis on how this intersection relates to health disparities. The training encompasses conceptual frameworks, study designs, data collection needs, and analytic approaches necessary to conduct this innovative research. The program includes an intensive 3-day summer institute in Ann Arbor, MI, followed by ongoing collaboration with a mentorship team.
This program is funded through OBSSR and NCCIH. It is the only NIH-funded program focused on building the methodological expertise needed to address the intersection of mental and physical health. This program will support efforts to increase cross-pollination in interdisciplinary scientific teams, and foster an integrative approach to clinical care and health services programming that can better meet the needs of persons with comorbid mental and physical health conditions.
Application Deadline: February 1, 2023
ORBIT Institute is now accepting applications for the ORBIT Institute 2023 cohort
The NIH-funded short course, ORBIT Institute: Developing Behavioral Treatments to Improve Health, will consist of an in-person workshop, May 15-18, 2023, in Tallahassee FL, followed by a series of virtual, bi-weekly webinars. A total of 100 Fellows (25 Fellows per year) will be accepted into the ORBIT Institute and trained in behavioral intervention development for cancer prevention/treatment and related health behaviors.
The deadline to apply is February 9, 2023.
The goals of the ORBIT Institute are:
- To increase the skills of Fellows in a phased approach, with associated innovative methods and designs for T1 translation of Behavioral and Social Sciences Research (BSSR) to improve health.
- To conduct an ongoing evaluation of the success of the skills development course based upon three basic metrics:
(a) perceived value
(b) the reach of the course based upon website hits, number of applications, and train the trainer activities
(c) the impact of the course on the career trajectories of the Fellows (publications, grants)
- To conduct ongoing curriculum development and refinement, as well as dissemination via technology, based upon results of quantitative and qualitative evaluations and new methodologies emerging over the grant period.
Recently Published Funding Announcements
Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed)
Open Date (Earliest Submission Date): March 14, 2023
Expiration Date: April 15, 2023
This Funding Opportunity Announcement (FOA) invites Planning Grant applications that conceptualize the design and implementation of a future national, interdisciplinary, patient-centered research collaborative that will advance Temporomandibular Disorders (TMDs) basic and clinical research, research training, and translation to evidence-based treatments and improved clinical care. The planning grants are intended to enable institutions to develop partnerships, infrastructure, and capabilities needed to address the major goals of a future Collaborative and develop a Collaborative-wide research framework and strategies to support coordination among studies, research projects, and sites, and thereby enhance competitiveness for future participation in TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT). The planning grant will not be a prerequisite for submission of a TMD IMPACT application.
BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)
Open Date (Earliest Submission Date): January 15, 2023
Expiration Date: February 16, 2024
This Funding Opportunity Announcement (FOA) supports the development and validation of next-generation tools, methods, and analytic approaches to precisely quantify behaviors and combine them with simultaneous recordings of brain activity in humans. Tools used for measuring and analyzing behavior should be multi-modal, with the appropriate accuracy, specificity, temporal resolution, and flexibility necessary for integration with existing tools used to measure and modulate the brain circuits that give rise to those behaviors.
Enhancing the Use of the All of Us Research Program’s Data (R21 Clinical Trial Not Allowed)
Open Date (Earliest Submission Date): January 29, 2023
Expiration Date: March 2, 2023
The All of Us Research Program (All of Us) within the Office of the Director (OD) encourages investigators to apply for grant awards that will advance research in high-priority mission areas of the Institutes, Centers, and Offices (ICOs) through two companion FOAs (1) one to use standard methods and approaches to analyze currently available data within the All of Us Research Program’s Researcher Workbench and (2) one to develop new methods, models, and tools and use them to analyze data in the Researcher Workbench. The new tools will be made broadly available to the scientific community. This FOA uses the R21 grant mechanism for new tool development and application, while the companion FOA (link) uses the R03 grant mechanism to support data analysis using standard methods.
Small Grants to Enhance the Use of the All of Us Research Program’s Data (R03 Clinical Trial Not Allowed)
Open Date (Earliest Submission Date): January 29, 2023
Expiration Date: March 2, 2023
The All of Us Research Program (All of Us) within the Office of the Director (OD) encourages investigators to apply for grant awards that will advance research in high-priority mission areas of the Institutes, Centers, and Offices (ICOs) through two companion FOAs (1) one to use standard methods and approaches to analyze currently available data within the All of Us Research Program’s Researcher Workbench and (2) one to develop new methods, models, and tools and use them to analyze data in the Researcher Workbench. The new tools will be made broadly available to the scientific community. This FOA uses the R03 grant mechanism to support data analysis using standard methods, while the companion FOA (link) uses the R21 mechanism for new tool development and application.